Drinking coffee can reduce common skin cancer

According to foreign media reports recently, a new study announced at the 10th International Conference on Frontiers in Cancer Prevention sponsored by the American Association for Cancer Research (AACR) found that drinking coffee can reduce the risk of basal cell carcinoma (BCC), one of the most common types of skin cancer, also known as basal cell epithelioma).

This prospective study investigated the association between coffee drinking and the risk of basal cell carcinoma, squamous cell carcinoma (SCC), and melanoma. Coffee consumption only reduced the risk of basal cell carcinoma, the study found. "Our new study shows that coffee drinking is an important measure to prevent basal cell carcinoma," said Fengju Song, a postdoctoral fellow at Harvard Medical School and lead researcher in the department of dermatology.

Dr. Song and his colleagues found that coffee consumption was inversely related to skin cancer risk. Men and women who drank three or more cups of coffee a day had a 9 percent and 20 percent lower risk of basal cell cancer, respectively, compared with those who drank less than one cup of coffee a month. However, drinking coffee did not reduce the risk of two other types of skin cancer (squamous cell carcinoma and melanoma). researchers

The analysis suggests that caffeine in coffee is likely to play a protective role. Decaffeinated coffee was not associated with a reduced risk of basal cell carcinoma.